Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?

about

Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?

Item

http://www.wikidata.org/entity/Q42316697

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@en

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@nl

type

Item

label

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@en

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@nl

prefLabel

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@en

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@nl

P1476

Can molecular biomarkers repla ...... e colorectal liver metastasis?

@en

P2093

Torhild Veen

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy

Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer.

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?

Association between KRAS mutation and lung metastasis in advanced colorectal cancer.

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases

Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.

KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.

P304

98-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4251/WJGO.V9.I3.98

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kjetil Søreide

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28344745

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5348630

http://www.w3.org/2001/XMLSchema#string